Tutaworn T, Nieves JW, Wang Z, Levin JE, et al. Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study. Osteoporos Int 2023 Jan 5:1-12. doi: 10.1007/s00198-022-06648.
PMID: 36602607